# AKBA (Akebia Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Akebia Therapeutics, Inc. reported $197.2M in revenue and a net loss of $44.56M for the trailing twelve months ended September 30, 2026 (down 37.2% year over year), with a 78.9% gross margin and a -15.7% operating margin.

- Canonical: https://convexityos.com/fundamentals/AKBA
- Markdown: https://convexityos.com/fundamentals/AKBA.md
- SEC CIK: 0001517022
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:46 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001517022&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $197.2M | -37.2% YoY |
| Operating Income | TTM | -$31.04M | -15.7% margin |
| Net Income | TTM | -$44.56M | -22.6% net margin |
| Diluted EPS | TTM | -$0.16 | Split-adjusted |
| Free Cash Flow | TTM | $13.86M | 7.0% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $159.3M | Total debt: $60.49M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $236.2M | $160.2M | $194.6M | $292.5M | $213.6M | $295.3M | $335.0M | $207.7M | $181.2M | $1.53M |
| Cost of Revenue | $39.46M | $63.18M | $74.15M | $85.57M | $153.4M | $295.9M | $145.3M | $7.77M | -- | -- |
| **Gross Profit** | $196.7M | $97.00M | $120.5M | $206.9M | $60.18M | -$601K | $189.7M | $200.0M | -- | -- |
| Research & Development | $62.36M | $37.65M | $63.08M | $130.0M | $147.9M | $218.5M | $323.0M | $291.0M | $230.9M | $115.8M |
| Selling, General & Admin | $107.5M | $106.5M | $100.2M | $138.6M | $174.2M | $153.9M | $149.5M | $87.06M | $27.01M | $22.21M |
| Total Operating Expenses | $173.2M | $147.5M | $166.7M | $287.7M | $325.5M | $375.8M | $476.0M | $378.1M | $257.9M | $138.0M |
| **Operating Income** | $23.50M | -$50.47M | -$46.26M | -$80.78M | -$265.3M | -$376.4M | -$286.3M | -$178.2M | -$76.67M | -$136.5M |
| **EBITDA** | $24.77M | -$12.97M | -$8.63M | -$79.12M | -$263.4M | -$374.4M | -$284.0M | -$177.3M | -$76.06M | -$136.2M |
| Interest Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $901K |
| Income Before Tax | -$3.72M | -$69.41M | -$51.92M | -$94.23M | -$282.8M | -$383.5M | -$286.3M | -$171.9M | -$73.67M | -$135.7M |
| Income Tax Expense | $1.62M | $0 | $0 | $0 | $0 | $0 | -$6.63M | -$28.34M | -- | -- |
| **Net Income** | -$5.34M | -$69.41M | -$51.92M | -$94.23M | -$282.0M | -$383.5M | -$279.7M | -$143.6M | -$73.67M | -$135.7M |
| Basic EPS | -$0.02 | -$0.33 | -$0.28 | -$0.52 | -$1.70 | -$2.77 | -$2.36 | -$2.47 | -$1.69 | -$3.60 |
| **Diluted EPS** | -$0.02 | -$0.33 | -$0.28 | -$0.52 | -$1.70 | -$2.77 | -$2.36 | -$2.47 | -$1.69 | -$3.60 |
| Basic Shares Outstanding | 257.2M | 210.9M | 187.5M | 182.8M | 165.9M | 138.5M | 118.4M | 58.0M | 43.5M | 37.7M |
| Diluted Shares Outstanding | 257.2M | 210.9M | 187.5M | 182.8M | 165.9M | 138.5M | 118.4M | 58.0M | 43.5M | 37.7M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $36.90M | $49.13M | $53.54M | $57.62M | $58.77M | $62.47M | $57.34M | $46.50M |
| Cost of Revenue | $6.36M | $10.42M | $12.29M | $12.54M | $9.38M | $9.92M | $7.62M | $20.36M |
| **Gross Profit** | $30.54M | $38.70M | $41.25M | $45.09M | $49.38M | $52.55M | $49.71M | $26.13M |
| Research & Development | $16.18M | $14.06M | $14.81M | $26.65M | $14.94M | $11.01M | $9.75M | $11.79M |
| Selling, General & Admin | $23.53M | $28.17M | $30.44M | $26.09M | $29.09M | $26.55M | $25.74M | $27.68M |
| Total Operating Expenses | $42.00M | $45.03M | $45.95M | $53.64M | $44.93M | $38.46M | $36.20M | $40.44M |
| **Operating Income** | -$11.46M | -$6.33M | -$4.70M | -$8.55M | $4.45M | $14.09M | $13.51M | -$14.31M |
| **EBITDA** | -$11.36M | -$5.74M | -$4.37M | -$8.23M | $4.77M | $14.40M | $13.83M | -$4.96M |
| Income Before Tax | -$14.18M | -$8.84M | -$8.93M | -$11.23M | $1.16M | $247K | $6.11M | -$22.80M |
| Income Tax Expense | $175K | $70K | $126K | $1.01M | $615K | $0 | $0 | -- |
| **Net Income** | -$14.35M | -$8.91M | -$9.05M | -$12.24M | $540K | $247K | $6.11M | -$22.80M |
| Basic EPS | -$0.05 | -$0.03 | -$0.03 | -- | $0.00 | $0.00 | $0.03 | -- |
| **Diluted EPS** | -$0.05 | -$0.03 | -$0.03 | -- | $0.00 | $0.00 | $0.03 | -- |
| Basic Shares Outstanding | 276.9M | 269.6M | 267.0M | -- | 264.8M | 262.6M | 235.5M | -- |
| Diluted Shares Outstanding | 276.9M | 269.6M | 267.0M | -- | 274.4M | 271.1M | 241.6M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $184.8M | $51.87M | $42.92M | $90.47M | $149.8M | $228.7M | $147.4M | $104.6M | $70.16M | $187.3M |
| Short-Term Investments | -- | -- | -- | -- | -- | -- | $245K | $216.8M | $217.9M | $65.07M |
| **Cash & Short-Term Investments** | $184.8M | $51.87M | $42.92M | $90.47M | $149.8M | $268.7M | $147.7M | $321.6M | $317.8M | $260.3M |
| Accounts Receivable, Net | $47.03M | $34.37M | $39.29M | $40.28M | $50.88M | $26.85M | $38.86M | $16.67M | $34.22M | $33.82M |
| Inventory | $15.61M | $16.24M | $15.69M | $21.57M | $38.20M | $61.02M | $116.3M | $114.2M | -- | -- |
| Other Current Assets | $3.77M | $7.32M | $5.75M | $17.25M | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $253.0M | $113.8M | $118.1M | $185.2M | $272.0M | $371.4M | $309.5M | $468.3M | $358.4M | $296.3M |
| Property, Plant & Equipment, Net | $1.22M | $2.20M | $3.63M | $5.21M | $6.75M | $8.62M | $10.38M | $8.02M | $3.62M | $2.61M |
| Goodwill | $59.04M | $59.04M | $59.04M | $59.04M | $55.05M | $55.05M | $55.05M | $55.05M | -- | -- |
| Intangible Assets | -- | $0 | $36.04M | $72.08M | $108.1M | $144.2M | $291.2M | $328.2M | -- | -- |
| Long-Term Investments | -- | -- | -- | -- | -- | -- | -- | $245K | $29.75M | $7.94M |
| Other Non-Current Assets | $59.68M | $37.38M | $12.42M | $5.37M | $49.75M | $37.98M | $75.98M | $137.0M | $2.27M | $1.28M |
| **Total Non-Current Assets** | $123.6M | $106.8M | $123.6M | $170.9M | $253.5M | $272.7M | $461.7M | $528.3M | $5.89M | $3.90M |
| **Total Assets** | $376.6M | $220.7M | $241.7M | $356.1M | $525.5M | $644.1M | $771.2M | $996.5M | $364.2M | $300.2M |
| Accounts Payable | $21.18M | $15.18M | $14.63M | $18.02M | $33.59M | $41.31M | $39.22M | $42.80M | $7.00M | $2.04M |
| Short-Term Debt | $0 | $0 | $17.50M | $32.00M | $97.54M | $0 | -- | $15.00M | -- | -- |
| Deferred Revenue (Current) | $2.68M | $0 | $0 | $3.74M | $20.91M | $15.21M | $39.83M | $56.98M | $81.67M | $81.97M |
| **Total Current Liabilities** | $162.9M | $80.91M | $99.87M | $129.5M | $256.5M | $187.1M | $208.1M | $265.7M | $141.1M | $114.3M |
| Long-Term Debt | $48.25M | $38.69M | $17.18M | $34.08M | $0 | $96.38M | $75.81M | -- | -- | -- |
| Deferred Revenue (Non-Current) | -- | $0 | $43.30M | $43.30M | $21.47M | $25.34M | $33.12M | $55.71M | $97.96M | $115.3M |
| Other Non-Current Liabilities | $1.82M | $4.75M | $8.88M | $15.72M | $82.53M | $60.61M | $30.22M | $29.57M | $22K | $27K |
| **Total Non-Current Liabilities** | $181.0M | $188.9M | $172.4M | $221.3M | $192.6M | $209.4M | $168.3M | $94.92M | $100.6M | $117.8M |
| **Total Liabilities** | $344.0M | $269.9M | $272.3M | $350.8M | $449.1M | $396.5M | $376.4M | $360.6M | $241.7M | $232.1M |
| **Total Debt (incl. Leases)** | $51.80M | $47.64M | $48.12M | $99.78M | $136.4M | $126.3M | $108.3M | $15.00M | -- | -- |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | $0 | $0 |
| Retained Earnings | -$1.68B | -$1.68B | -$1.61B | -$1.56B | -$1.46B | -$1.18B | -$794.1M | -$514.4M | -$370.8M | -$297.1M |
| Accumulated Other Comp. Income | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $13K | $0 | -$261K | -$442K | -$42K |
| **Total Stockholders' Equity** | $32.61M | -$49.19M | -$30.58M | $5.23M | $74.01M | $247.6M | $394.8M | $635.9M | $122.6M | $68.12M |
| Total Equity | $32.61M | -$49.19M | -$30.58M | $5.23M | $74.01M | $247.6M | $394.8M | $635.9M | $122.6M | $68.12M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $159.3M | $155.5M | $162.6M | $184.8M | $166.4M | $137.3M | $113.4M | $51.87M |
| **Cash & Short-Term Investments** | $159.3M | $155.5M | $162.6M | $184.8M | $166.4M | $137.3M | $113.4M | $51.87M |
| Accounts Receivable, Net | $36.44M | $53.51M | $62.54M | $47.03M | $66.22M | $72.81M | $61.54M | $34.37M |
| Inventory | $18.70M | $13.02M | $13.00M | $15.61M | $18.64M | $16.71M | $19.73M | $16.24M |
| Other Current Assets | $6.39M | $5.77M | $3.60M | $3.77M | $5.33M | $7.83M | $7.92M | $7.32M |
| **Total Current Assets** | $220.8M | $229.6M | $243.5M | $253.0M | $258.3M | $234.7M | $203.8M | $113.8M |
| Property, Plant & Equipment, Net | $2.40M | $1.51M | $956K | $1.22M | $1.47M | $1.71M | $1.90M | $2.20M |
| Goodwill | $59.04M | $59.04M | $59.04M | $59.04M | $59.04M | $59.04M | $59.04M | $59.04M |
| Intangible Assets | -- | -- | -- | -- | -- | -- | -- | $0 |
| Other Non-Current Assets | $50.22M | $53.75M | $56.57M | $59.68M | $40.46M | $44.19M | $38.34M | $37.38M |
| **Total Non-Current Assets** | $121.3M | $120.1M | $119.0M | $123.6M | $105.8M | $110.9M | $106.4M | $106.8M |
| **Total Assets** | $342.1M | $349.7M | $362.5M | $376.6M | $364.2M | $345.6M | $310.2M | $220.7M |
| Accounts Payable | $7.61M | $9.42M | $8.39M | $21.18M | $10.09M | $11.55M | $12.66M | $15.18M |
| Short-Term Debt | $37.49M | $24.81M | $12.49M | $0 | -- | -- | -- | $0 |
| Deferred Revenue (Current) | $4.96M | $6.17M | $4.50M | $2.68M | $3.88M | $5.53M | $1.24M | $0 |
| **Total Current Liabilities** | $162.3M | $160.9M | $173.9M | $162.9M | $133.4M | $118.7M | $91.23M | $80.91M |
| Long-Term Debt | $12.78M | $24.75M | $36.40M | $48.25M | $47.64M | $47.06M | $46.51M | $38.69M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | -- | $0 |
| Other Non-Current Liabilities | $897K | $562K | $681K | $1.82M | $5.00M | $5.36M | $5.11M | $4.75M |
| **Total Non-Current Liabilities** | $159.4M | $163.8M | $161.3M | $181.0M | $189.2M | $197.7M | $194.4M | $188.9M |
| **Total Liabilities** | $321.8M | $324.6M | $335.1M | $344.0M | $322.6M | $316.4M | $285.6M | $269.9M |
| **Total Debt (incl. Leases)** | $60.49M | $54.90M | $51.02M | $51.80M | $52.58M | $53.36M | $54.15M | $47.64M |
| Common Stock | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K |
| Retained Earnings | -$1.72B | -$1.70B | -$1.69B | -$1.68B | -$1.67B | -$1.67B | -$1.67B | -$1.68B |
| Accumulated Other Comp. Income | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K |
| **Total Stockholders' Equity** | $20.37M | $25.02M | $27.38M | $32.61M | $41.59M | $29.22M | $24.58M | -$49.19M |
| Total Equity | $20.37M | $25.02M | $27.38M | $32.61M | $41.59M | $29.22M | $24.58M | -$49.19M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$5.34M | -$69.41M | -$51.92M | -$92.56M | -$282.8M | -$383.5M | -$279.7M | -$143.6M | -$73.67M | -$135.7M |
| Depreciation & Amortization | $1.27M | $37.50M | $37.63M | $1.65M | $1.93M | $2.08M | $2.25M | $899K | $617K | $296K |
| Stock-Based Compensation | $11.28M | $7.78M | $9.32M | $17.85M | $22.73M | $24.46M | $11.93M | $19.04M | $8.87M | $5.83M |
| Change in Receivables | -$14.14M | $4.05M | $994K | $11.30M | -$24.02M | $12.01M | -$22.20M | $33.38M | -$393K | -$33.82M |
| Change in Inventory | -$23.12M | -$28.40M | -$2.54M | $19.09M | -$25.85M | $6.16M | -$29.14M | $26K | -- | -- |
| Change in Payables | $3.08M | -$1.36M | -$5.24M | $1.50M | -$11.73M | $3.68M | $1.37M | $13.72M | $4.96M | -$274K |
| **Operating Cash Flow** | $67.99M | -$40.66M | -$23.38M | -$73.15M | -$253.0M | -$110.4M | -$257.4M | -$97.49M | -$56.16M | $57.91M |
| Capital Expenditure | -$291K | -$33K | $0 | -$114K | -$59K | -$317K | -$6.66M | -$1.61M | -$1.62M | -$2.66M |
| **Free Cash Flow** | $67.70M | -$40.69M | -$23.38M | -$73.27M | -$253.0M | -$110.7M | -$264.1M | -$99.10M | -$57.78M | $55.24M |
| Purchases of Investments | -- | -- | -- | $0 | $0 | -$99.93M | $0 | -$224.2M | -$330.6M | -$147.0M |
| Sales & Maturities of Investments | -- | -- | -- | -- | $40.00M | $60.24M | $217.8M | $256.3M | $155.0M | -- |
| **Investing Cash Flow** | -$7.93M | -$33K | $0 | -$114K | $39.94M | -$40.00M | $211.2M | $36.59M | -$177.3M | $12.71M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | -- | $373.1M | -- |
| **Financing Cash Flow** | $72.93M | $49.66M | -$25.21M | $14.60M | $133.7M | $231.7M | $88.97M | $96.56M | $116.2M | $66.95M |
| **Net Change in Cash** | $133.0M | $8.97M | -$48.59M | -$58.67M | -$79.29M | $81.33M | $42.70M | $35.66M | -$117.2M | $137.6M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$14.35M | -$8.91M | -$9.05M | -$12.24M | $540K | $247K | $6.11M | -$22.80M |
| Depreciation & Amortization | $101K | $585K | $328K | $321K | $318K | $316K | $314K | $9.35M |
| Stock-Based Compensation | $2.80M | $3.23M | $3.67M | $3.20M | $3.22M | $2.68M | $2.19M | $1.70M |
| Change in Receivables | $16.97M | $9.03M | -$15.70M | $19.10M | $6.16M | -$11.53M | -$27.87M | -$3.07M |
| Change in Inventory | -$1.65M | -$655K | -$2.54M | -$17.42M | $6.90M | -$7.65M | -$4.95M | -$8.50M |
| Change in Payables | -$2.58M | $2.60M | -$7.79M | $10.42M | -$8.83M | $3.73M | -$2.23M | $2.39M |
| **Operating Cash Flow** | $2.33M | $3.52M | -$21.21M | $31.13M | $28.11M | $22.34M | -$13.59M | -$4.47M |
| Capital Expenditure | -$706K | -$1.08M | -$62K | -$70K | -$77K | -$126K | -$18K | -$2.0K |
| **Free Cash Flow** | $1.63M | $2.45M | -$21.27M | $31.06M | $28.03M | $22.22M | -$13.61M | -$4.47M |
| **Investing Cash Flow** | -$2.61M | -$4.08M | -$62K | -$7.88M | -$77K | -$126K | $154K | -$2.0K |
| **Financing Cash Flow** | $3.18M | -$6.54M | -$926K | -$4.85M | $1.11M | $1.72M | $74.94M | $22.32M |
| **Net Change in Cash** | $2.90M | -$7.09M | -$22.20M | $18.40M | $29.14M | $23.94M | $61.51M | $17.86M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 83.3% | 60.6% | 61.9% | 70.7% | 28.2% | -0.2% | 56.6% | 96.3% | -- | -- |
| **Operating Margin** | 9.9% | -31.5% | -23.8% | -27.6% | -124.2% | -127.5% | -85.5% | -85.8% | -42.3% | -8889.9% |
| **Net Profit Margin** | -2.3% | -43.3% | -26.7% | -32.2% | -132.0% | -129.9% | -83.5% | -69.1% | -40.7% | -8843.5% |
| Return on Equity (ROE) | -16.4% | -- | -- | -1801.6% | -381.1% | -154.9% | -70.8% | -22.6% | -60.1% | -199.3% |
| Return on Assets (ROA) | -1.4% | -31.5% | -21.5% | -26.5% | -53.7% | -59.5% | -36.3% | -14.4% | -20.2% | -45.2% |
| Current Ratio | 1.55x | 1.41x | 1.18x | 1.43x | 1.06x | 1.98x | 1.49x | 1.76x | 2.54x | 2.59x |
| Quick Ratio | 1.46x | 1.21x | 1.03x | 1.26x | 0.91x | 1.66x | 0.93x | 1.33x | 2.49x | 2.57x |
| Debt to Equity | 1.59x | -- | -- | 19.08x | 1.84x | 0.51x | 0.27x | 0.02x | -- | -- |
| **Revenue Growth (YoY)** | +47.5% | -17.7% | -33.5% | +36.9% | -27.7% | -11.8% | +61.3% | +14.6% | +11706.3% | -- |
| Gross Profit Growth (YoY) | +102.8% | -19.5% | -41.8% | +243.8% | -- | -100.3% | -5.2% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -197.0% | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -204.6% | -- |
| 5Y Revenue / Share Growth | -56.9% | -73.2% | -71.0% | -61.6% | +3062.3% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 78.9% | 79.6% | 81.0% | 83.3% | 79.0% | 74.4% | 68.0% | 60.6% |
| **Operating Margin** | -15.7% | -6.9% | 2.3% | 9.9% | 7.9% | 0.4% | -11.9% | -31.5% |
| **Net Profit Margin** | -22.6% | -13.5% | -8.8% | -2.3% | -7.1% | -17.9% | -24.5% | -43.3% |
| Return on Equity (ROE) | -218.8% | -118.6% | -74.9% | -16.4% | -38.2% | -124.8% | -184.3% | -- |
| Return on Assets (ROA) | -13.0% | -8.5% | -5.7% | -1.4% | -4.4% | -10.6% | -14.6% | -31.5% |
| Current Ratio | 1.36x | 1.43x | 1.40x | 1.55x | 1.94x | 1.98x | 2.23x | 1.41x |
| Quick Ratio | 1.24x | 1.35x | 1.33x | 1.46x | 1.80x | 1.84x | 2.02x | 1.21x |
| Debt to Equity | 2.97x | 2.19x | 1.86x | 1.59x | 1.26x | 1.83x | 2.20x | -- |
| **Revenue Growth (YoY)** | -37.2% | -21.4% | -6.6% | +23.9% | +57.0% | +43.1% | +75.8% | -17.3% |
| Gross Profit Growth (YoY) | -38.2% | -26.4% | -17.0% | +72.5% | +112.2% | +97.6% | +136.7% | -30.4% |
| Operating Income Growth (YoY) | -357.6% | -144.9% | -134.7% | -- | -- | -- | -- | -1141.3% |
| **Net Income Growth (YoY)** | -2758.1% | -3706.5% | -248.1% | -- | -- | -- | -- | -3814.0% |
| EPS Growth (YoY) | -- | -- | -200.0% | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -91.7% | -84.2% | -- | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -94.2% | -89.0% | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
